secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0000950170-24-071338
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo stockholders elect two directors, ratify Moss Adams as auditor for 2024
------------------------------------------------------------------------------

- Daniel J. Abdun-Nabi and Grady Grant III elected to board with ~470K votes for each.
- Ratification of Moss Adams as independent auditor for 2024: 1,271,108 for, 232,874 against.
- Second Amended and Restated 2018 Stock Incentive Plan approved: 442,849 for, 355,401 against.
- Non-binding advisory vote on executive compensation approved: 436,765 for, 365,824 against.
- Broker non-votes of ~704K were present on director election and incentive plan proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024071338/0000950170-24-071338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024071338/apvo-20240607.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-071338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer